GT Biopharma press release (GTBP): Q2 net loss for the second quarter of 2026 of approximately $4.5 million, compared to $30.2 million for the same comparable quarter of 2025.
$GTBP
Price history, market instrument context, member research, and related headlines in one place.
GTBP key statistics
NasdaqCMUSD
52-week range
$4.915%$28.75
Latest session $5.90–$6.44GT Biopharma, Inc. (GTBP) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $6.21, down $0.29 (4.46%) from the previous close of $6.50. It has traded between $5.90 and $6.44 in the latest session. Over the past year it has ranged from $4.91 to $28.75, leaving it in the lower quarter of its 52-week range (5%). Reported volume for the session was 42K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $GTBP research…